Asparaginase (ASNase)-based chemotherapy regimens significantly improve survival outcomes in children. adolescent and young adult (AYA). and even adults with acute lymphoblastic leukemia/lymphoma (ALL); however. the incidence and severity of ASNase-associated adverse events (AEs) in adults may differ significantly from those reported in children. https://www.spidertattooz.com/